ALTEVAX
Altevax is developing and will bring to market an entirely new vaccine technology for cancer and infectious diseases. This patented technology, which consists in a melanin-based adjuvant embedding an antigen, has shown superior efficacy in treating tumours relative to existing methods. In multiple lab tests, the technology was proven to trigger a very powerful immune response against cancers and viruses, demonstrating dramatically superior effectiveness relative to current cancer vaccines benchm... arks. The Altevax technology triggers antigen-specific Cytotoxic T-lymphocytes (CTLs), the organism's most effective defenders. These antigen-specific CTLs destroy the cancerous cells while leaving heathy cells intact. Melanin is a non-toxic compound, naturally present compound in the human body and responsible for the skin's colour. Unlike other vaccines in the market or under development today that present significant toxicity issues, the Altevax technology is therefore likely to have no or very limited toxic effect.
ALTEVAX
Social Links:
Industry:
Biotechnology
Founded:
2016-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.altevax.com
Total Employee:
1+
Status:
Active
Contact:
+33 9 70 40 54 00
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Content Delivery Network SSL By Default HSTS Microsoft Exchange Online Office 365 Mail
Similar Organizations
Antoxis
Antoxis is developing treatments for various neurological conditions.
Investors List
AGORANOV
AGORANOV investment in Venture Round - Altevax
Official Site Inspections
http://www.altevax.com Semrush global rank: 13.98 M Semrush visits lastest month: 67
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Altevax"
Altevax | A first-in-class immunotherapy against cancer
Altevax is committed to bringing its innovative anticancer and anti-infectious technology to patients, to treat diseases that have no available cure today. Using melanin as an adjuvant, …See details»
Altevax - Crunchbase Company Profile & Funding
Altevax is developing and will bring to market an entirely new vaccine technology for cancer and infectious diseases. This patented technology, which consists …See details»
Altevax Company Profile 2024: Valuation, Funding & Investors
Altevax General Information Description. Developer of a therapeutic vaccine intended for breakthrough immunotherapy technology, using a melanin-based adjuvant. The company's …See details»
Altevax Biotech - LinkedIn
Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen …See details»
ALTEVAX - Societe.com
ALTEVAX, société par actions simplifiée, au capital social de 2704,69 EURO, dont le siège social est situé au 55 AVENUE MARCEAU, 75016 PARIS, immatriculée au Registre du Commerce …See details»
Altevax Company Profile - Office Locations, Competitors ... - Craft
Altevax is a company that develops and markets a vaccine technology for cancer and infectious diseases. Its technology triggers antigen-specific Cytotoxic T-lymphocytes (CTLs), the …See details»
14 Polytechnique start-ups innovating for the future
May 15, 2020 Altevax: Synthesizing melanin to boost the immune system . Altevax has developed an immunotherapy treatment based on a patent filed by Professor Antoine …See details»
Victor Vadaneaux Profile: Contact Information & Network
Mr. Victor Vadaneaux is a Co-Founder & serves as Board Member at Altevax. He serves as Board Member at Odfjell Technology. He served as Advisor and Board Member at Ability …See details»
Vaccines, innovation and l’X ecosystem - École polytechnique
Jan 21, 2021 Altevax has developed an immunotherapy treatment based on a patent filed by Professor Antoine Carpentier of the Saint-Louis Hospital (Paris) on the power of melanin to …See details»
L’X, l’innovation et les vaccins - École polytechnique, école d ...
Jan 21, 2021 Altevax : Synthétiser la mélanine pour doper le système immunitaire. Co-fondée en 2016 par Victor Vadaneaux (X 83), spécialiste des biotechs et du management d’entreprise, et …See details»
Altevax Biotech on LinkedIn: #immunotherapy #vaccine #cancer # ...
Altevax Founder Pr Antoine Carpentier presented at the EANO European Association of Neuro-Oncology Meeting 2023 in Rotterdam. To discover the abstract and…See details»
Alevax AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alevax AB of Malmö, Skåne. Get the latest business insights from Dun & Bradstreet.See details»
ALTRAVAX, INC. Company Profile | Fargo, ND - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALTRAVAX, INC. of Fargo, ND. Get the latest business insights from Dun & Bradstreet.See details»
Efficacy and safety of bevacizumab in glioblastomas - PubMed
Glioblastoma multiforme (GBM) is a common and malignant primary brain tumor arising from glial precursors the survival of which is estimated to be about 14 months after diagnosis despite …See details»
14 start-up de l’X qui innovent pour demain - École polytechnique ...
Antoine Carpentier s’est associé fin 2016 à Victor Vadaneaux (X 83), spécialistes des biotechs et du management d’entreprise pour fonder Altevax. La start-up a testé son vaccin thérapeutique …See details»
Altevax - Company Profile - Tracxn
Altevax - Developer of antigen-specific CTLs technology for treating cancer. Founded by Victor Vadaneaux and Antoine Carpentier in the year 2016. Altevax has 2798 competitors.See details»
Altravax, Inc. Company Profile | Foster City, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Altravax, Inc. of Foster City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Altravax Company Profile 2024: Valuation, Funding & Investors
Altravax General Information Description. Developer of immunogen optimization vaccines designed to improve human health, both individually and globally. The company's vaccines …See details»
AltraVax - Company Profile - Tracxn
Oct 11, 2024 Altravax focuses on the discovery and development of new vaccines and the improvement of existing vaccines to fight infectious diseases. Its product pipeline includes a …See details»